Trudeau’s drug price overhaul is set to cost drug makers billions

Bloomberg

6 September 2019 - Canada revamps drug-pricing regime for first time since 1987.

Prime Minister Justin Trudeau is overhauling Canada’s drug-pricing regime for the first time in more than 30 years, a move that could cost drugmakers billions in sales and raise the stakes in a U.S. debate over prescription costs.

Trudeau, who is trying to fend off a conservative challenger in an election in October, has pushed through new regulations to drop the U.S. from a basket of countries Canada uses to cap domestic drug prices. The move is part of a wider revamp that marks “the biggest step to lower drug prices in a generation,” said Health Minister Ginette Petitpas Taylor.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Canada